Radiation‐Induced Oral Mucositis Hamster Model Using a Linear Accelerator Enhances Clinical Relevance of Preclinical Studies for Treatment Strategy Investigation by Jordan, Carolyn T. et al.
University of Kentucky 
UKnowledge 
Radiation Medicine Faculty Publications Radiation Medicine 
1-26-2021 
Radiation‐Induced Oral Mucositis Hamster Model Using a Linear 
Accelerator Enhances Clinical Relevance of Preclinical Studies for 
Treatment Strategy Investigation 
Carolyn T. Jordan 
University of Kentucky 
Emily M. Bradford 
University of Kentucky, emily.bradford@uky.edu 
Dennis C. Cheek 
University of Kentucky, dennis.cheek@uky.edu 
Mahesh R. Kudrimoti 
University of Kentucky, mkudr0@email.uky.edu 
Craig S. Miller 
University of Kentucky, craig.miller@uky.edu 
See next page for additional authors 
Follow this and additional works at: https://uknowledge.uky.edu/radmed_facpub 
 Part of the Chemical Engineering Commons, and the Radiology Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Jordan, Carolyn T.; Bradford, Emily M.; Cheek, Dennis C.; Kudrimoti, Mahesh R.; Miller, Craig S.; Smith, 
Molly H.; Hilt, J. Zach; and Dziubla, Thomas D., "Radiation‐Induced Oral Mucositis Hamster Model Using a 
Linear Accelerator Enhances Clinical Relevance of Preclinical Studies for Treatment Strategy 
Investigation" (2021). Radiation Medicine Faculty Publications. 26. 
https://uknowledge.uky.edu/radmed_facpub/26 
This Article is brought to you for free and open access by the Radiation Medicine at UKnowledge. It has been 
accepted for inclusion in Radiation Medicine Faculty Publications by an authorized administrator of UKnowledge. 
For more information, please contact UKnowledge@lsv.uky.edu. 
Radiation‐Induced Oral Mucositis Hamster Model Using a Linear Accelerator 
Enhances Clinical Relevance of Preclinical Studies for Treatment Strategy 
Investigation 
Digital Object Identifier (DOI) 
https://doi.org/10.1002/ame2.12148 
Notes/Citation Information 
Published in Animal Models and Experimental Medicine, v. 4, issue 1. 
© 2021 The Authors 
This is an open access article under the terms of the Creative Commons 
Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, 
provided the original work is properly cited, the use is non‐commercial and no modifications or 
adaptations are made. 
Authors 
Carolyn T. Jordan, Emily M. Bradford, Dennis C. Cheek, Mahesh R. Kudrimoti, Craig S. Miller, Molly H. 
Smith, J. Zach Hilt, and Thomas D. Dziubla 
This article is available at UKnowledge: https://uknowledge.uky.edu/radmed_facpub/26 
Anim Models Exp Med. 2021;4:47–53.    |  47wileyonlinelibrary.com/journal/ame2
1  | INTRODUC TION
Oral mucositis (OM) affects a significant number of head and neck 
cancer patients receiving high doses of radiation or chemotherapy.1,2 
It is a debilitating side effect that damages healthy epithelial tissue 
in the oral cavity and can result in severe ulcers. High dose radio-
therapy often damages tissue via oxidative stress (OS), where the 
antioxidant-free radical concentration becomes imbalanced. High-
energy radiation may directly damage DNA or indirectly induce 
hydroxyl radical formation. The initiation of free radical generation 
triggers secondary messenger and signaling cascades that induce 
cell damage and apoptosis.3 Downstream, pro-inflammatory cyto-
kines infiltrate the submucosa and amplify injury.4 This may lead to 
destruction of the mucosal epithelium and superficial or transmural 
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Abstract
Translational animal models for oral mucositis (OM) are necessary to simulate and 
assess the bioclinical effects and response in humans. These models should simulate 
high levels of radiation exposure that leads to oxidative stress and inflammatory-
initiated tissue changes. Hamster models have been extensively studied to observe 
pathological effects of radiation exposure and help in the development of effective 
treatments. To successfully evaluate the potential for treatment regimens with con-
sistency and relevance, a radiation-induced OM hamster model was developed using 
a clinical linear accelerator utilized by cancer patients daily. The dose exposure to the 
isolated, everted cheek pouch of a hamster, as well as the progression of injury, pro-
inflammatory marker, histological, and elasticity analyses of the buccal pouch were 
conducted to verify replicability and reproducibility of the injury model. The findings 
from this model demonstrated its ability to consistently induce injury and resolution 
over 28 days using an acute dose of 60 Gy. This model was developed to enhance 
clinical relevance when evaluating potential efficacious treatments and can now be 
utilized in efficacy studies to better evaluate developed therapeutics in a preclinical 
model that is easy to translate to clinical studies..
K E Y W O R D S
animal models, radiotherapy, stomatitis
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ulceration. Unfortunately, OM does not have effective treatments, 
and costs can be measured financially as well as by delay in cancer 
therapy.
Animal models build upon in vitro studies and play a critical 
role in preclinical studies that serve as a translational pathway for 
drug discovery. Hamsters have been used extensively to study the 
pathogenesis and inflammatory processes involved in OM.5-11 The 
similar characteristics of the hamster and human oral cavity, that is, 
similar onset of OM, bacterial flora and blood cell count contribute 
to its appeal.9,12 In prior investigations, oral ulcers in hamsters have 
been induced on everted, localized cheek pouches, and evaluated 
for onset, peak injury, and resolution of injury up to 28 days using 
sources such as a 250-kV potential (1-15 mA) source hardened with 
Cu or Al-filtration system to deliver 40 Gy,5,7,9, megavoltage through 
cobalt-60,10 or even induction through chemotherapeutic adminis-
tration of 5-flurouracil and artificial irritation by scratching the mu-
cosa.12 While these models are all effective in inducing mucositis, 
variation in the source, as well as artificial injury, can create varied 
injury making the findings difficult to translate into clinical studies.
In this communication, we present a precise, effective method to 
induce localized OM using a Truebeam linear accelerator in golden 
Syrian hamsters. This same instrument is used to treat thousands 
of cancer patients each day around the world. The use of a clinical 
instrument strengthens the translational impact of this model. The 
aim of this study was to determine the dose necessary to achieve 
injury and resolution within a 28-day window and provide end point 
analyses of pro-inflammatory marker levels, histological analysis, 
and elasticity of the hamster pouch.
2  | MATERIAL S AND METHODS
2.1 | Animals
Four to six-week-old female and male golden Syrian hamsters with 
starting weights between 90 and 110 g were used for the radiation-
induced OM model development (Envigo, Haslett, MI). Animals 
were housed individually, with environmental enrichment provided 
throughout the duration of the study. Standard rodent chow pel-
lets (Envigo), non-fruit/vegetable food enrichment, and water were 
available ad libitum. All protocols were approved by the University of 
Kentucky Institutional Animal Care and Use Committee.
2.2 | Anesthesia
Prior to radiation, male hamsters were given 100 mg/kg ketamine 
(Henry Schein, Dublin, Ohio) in combination with 10 mg/kg xyla-
zine (AnaSed, Sigma-Aldrich, St. Louis, MO intraperitoneally (IP), 
whereas females received 10% more ketamine and xylazine to main-
tain anesthesia for the duration of exposure. On average, hamsters 
reached an appropriate plane of anesthesia (even breathing, lack of 
pedal, and corneal reflex) in 5-10 minutes and this was sustained for 
45 minutes. An additional dose of ketamine only (30 mg/kg) was 
given 10 minutes following the initial dose if hamsters were not suf-
ficiently anesthetized. Ophthalmic lubrication (Puralube, Dechra 
Veterinary Products, Overland Park, KS) was used to protect the 
eyes. Following irradiation, hamsters were placed on a heating pad 
and allowed to recover. Hamsters that were not ambulatory 30 min-
utes after anesthesia received 0.2 mg/kg atipamezole (Antisedan; 
Zoetis, Parsippany, NJ) IP to reverse the xylazine. Doses higher than 
0.2 mg/kg caused discernible agitation with no improvement in re-
covery time.
2.3 | Dose-dependent radiation
A pilot study was performed to determine the optimal radiation dose 
to achieve progression and resolution of OM over a 28-day period. 
Hamsters were randomly divided into three groups and subjected 
to 20 (n = 2), 40 (n = 4), or 60 Gy (n = 4) using the 6-MV photon 
beam from a Varian Truebeam linear accelerator. Once anesthetized, 
the left cheek pouch of each hamster was extracted outside of the 
oral cavity (inverted) using blunt forceps and held in place using an 
acrylic clamp with a 1-mm spacer to inhibit constriction of blood 
flow (Figure 1). Water equivalent bolus was placed on top of the 
acrylic clamp, so the depth of the tissue was at the maximum depth 
dose (1.5 cm) for the 6 MV beam. High-energy 6MV x-rays were de-
livered locally to the everted pouch in 15 × 15 cm field, exposing 
the pouches for a total delivery 20, 40, and 60 Gy as a one-time 
dose (from 3 to 10 minutes). The three different doses of radiation 
were compared by daily observation and scored using an OM ru-
bric (Table 1) over 28 days. Based on these limited pilot data, 60 Gy 
generated both sufficient injury and resolution over the 28-day time 
course and was used for all further studies (see Results). Combined 
with subsequent studies, a total of 22 hamsters (n = 11 male and 
F I G U R E  1   Hamster pouches everted and isolated by acrylic 
clamps designed for localized exposure to the field using the LINAC 
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n = 11 female) over 5 independent rounds of 60 Gy acute radiation 
were evaluated.
2.4 | Evaluation of the progression of injury
Hamsters were evaluated daily by taking the weight and scoring the 
everted cheek pouch for OM based on a six-point system developed 
by Sonis et al with modification to the scale due to the presence of fi-
brotic tissue during the resolution period found in Table 1.7 Targeted 
points of interest were (a) the day in which erythema was present, 
(b) the day in which peak injury occurred, and (c) the day injury was 
resolved or the 28th day of the study, whichever occurred first.
To evert the cheek pouches for evaluation, hamsters were 
anesthetized with 5% isoflurane/O2 in an induction chamber and 
maintained at 2.5% isoflurane/O2 delivered through a nose cone. 
Forceps were gently inserted into the oral cavity and the pouch was 
everted by clasping the base of the pouch and inverting it outside of 
the mouth for observation. Evaluation of the top and bottom of the 
pouch was completed while stretched into a triangular configuration. 
Pictures were taken using an Olympus Tough TG-5 camera in the 
microscope setting for close-up imaging with a ruler present in each 
picture. The entire procedure took less than 2 minutes per hamster. 
The cheek pouches were scored blindly at the time of evaluation 
by two trained individuals. To maintain pain management and care 
of the animals, hamsters that had a score of 3 were administered 
0.1 mg/kg buprenorphine IP once daily, and scores 4 and greater 
received 0.1 mg/kg buprenorphine IP twice daily. Hamsters that 
lost weight over 2 days were given a hydrogel water cup (ClearH2O, 
Portland, ME) to help reduce dehydration. Loss of 20% body weight 
was a considered a humane endpoint, which occurred in less than 
0.5% of the sample size (n = 22).
2.5 | Quantitative elasticity measurements
The widest part of the hamster pouch, the hypotenuse of the ex-
tracted pouch, was quantitatively evaluated at three time points of 
interest: baseline (day 0), peak injury (day 18), and end point (day 28) 
to compare elasticity throughout the study (n = 22). Widths of the 
extracted pouches were normalized to the starting values to deter-
mine change in elasticity.
2.6 | Tissue collection for H&E and OS markers
On day 28, hamsters were euthanized using isoflurane overdose 
and bilateral thoracotomy. The left and right cheek pouches were 
excised, and each cheek pouch was cut in half. One half was pinned 
and fixed in 10% neutral buffered formalin (NBF), and the other half 
was snap frozen in liquid nitrogen and stored at −80°C for tissue pro-
cessing for ELISAs of various oxidative stress and pro-inflammatory 
biomarkers including protein carbonyl, 4-HNE, TNF-α, IL-10, and 
IL-6, respectively.
Tissues that were fixed in 10% NBF overnight were then pro-
cessed through paraffin, sectioned at 5 μm, and stained with hema-
toxylin and eosin (H&E). Slides were imaged on an Olympus BX41 
microscope with a mounted Olympus DP71 camera.
For biomarker analysis, the frozen pouches were weighed and a 
target tissue concentration of 200 mg/mL in a 1x protease cocktail 
inhibitor was used to extract protein content from the connective 
tissue using a glass tissue homogenizer. A bicinchoninic acid assay 
(BCA) was used to determine protein levels. Enzyme-linked immu-
nosorbent assays (ELISA) were performed according to the manu-
facturer’s protocol. These included TNF-α, 4-HNE, protein carbonyl, 
IL-10, and IL-6 (MyBioSource, San Diego, CA). Each marker is re-
ported in molar concentration per milligram protein within the lin-
earity of the assay.
2.7 | Statistical analysis
For all figures, error bars represent standard error of the mean 
(SEM). The elasticity measurements were analyzed using a one-way 
ANOVA to evaluate significance between the start, peak, and end 
point analysis (P < .05) and the inflammatory marker analysis utilized 
the Dunnett’s test for uneven sample size populations (basal level 
[n = 5] vs 60 Gy exposure [n = 22]).
Score Description
0 Pouch completely healthy. No erosion or vasodilation.
1 Erythema. Slight fibrosis between days 19 and 28.
2 Severe erythema, vasodilation, and superficial erosion. Fibrosis present between days 
19 and 28.
3 Formation of ulcer, plaque covered ulcer, exophytic mass, or fibrotic tissue (in days 
19-28 only) in one or more places, but not affecting more than 25% of the surface 
area of the pouch. Severe erythema and vasodilation.
4 Cumulative ulcer formation, plaque covered ulcer, exophytic mass, or fibrotic tissue 
(in days 19-28 only)) in ~50% of pouch surface area.
5 Complete ulceration, plaque formation, exophytic mass, or fibrotic tissue (in day 
19-28 only) covering the entire pouch and/or unable to extract.
TA B L E  1   Modified rubric based on 
Sonis et al. to evaluate progression of 
observational injury of the duration of the 
study
50  |     JORDAN et Al.
3  | RESULTS
3.1 | Dose-dependent radiation
Cheek pouches were evaluated two times at baseline, 24 hours apart, 
and then irradiated. (Figure 2A). To immobilize hamsters during lo-
calized dosing of radiation, anesthetic was required. Female ham-
sters had a higher tolerance for anesthesia, and it was necessary to 
use 10% more ketamine and xylazine to induce and maintain the an-
esthetic plane. To evaluate injury progression, photo documentation 
was collected on days 2-27, and the pouch was blindly scored using 
the modified rubric in Table 1. Onset of injury was similar in all three 
radiation groups, with tissue irritation observed initially between 
days 8 and 12 after radiation. The onset of slight erythema was 
observed at day 14 for the 20 Gy exposure group and by day 12 
in the 40 Gy and 60 Gy groups (unirradiated control hamsters did 
not develop erythema or ulceration). Peak damage was significantly 
different among the three groups. Hamsters exposed to localized 
exposure of 20 Gy never had an OM score of greater than 1.0. The 
groups exposed to 40 Gy had injury progress from erythema to slight 
mucosal sloughing; however, they resolved completely back to base-
line after 22 days without formation of ulcers. At 60 Gy, the entire 
mucosal lining was completely disrupted from the pouch and ulcers 
formed within the bed of the cheek in all hamsters. The peak day of 
injury was day 18, at which time the pouches were swollen, chal-
lenging to evert, and over 50% of the pouch surface was ulcerated 
(Figure 2D). After peak injury, pouches scoring 1 quickly resolved by 
day 24. The acute dose evaluation was repeated with 40 and 60 Gy 
exposure groups (ie, a total of four hamsters in each group) to be able 
to calculate the average and SEM (Figure 2B). The replicability and 
consistency of the 60 Gy dose was further evaluated with a large 
sample size (n = 22) to show precision of model and injury-mediated 
ulceration (Figure 2C) with an overall survival rate of 100% through-
out the entirety of the study.
3.2 | Elasticity of pouch
Hamsters exposed to 60 Gy (n = 22) demonstrated pouch elastic-
ity changes. The pouch elasticity appears to change significantly 
(P < .05) between day 0 (start) and day 18 (peak injury) and start and 
end point analysis, where no change in elasticity appears to occur 
after peak injury. The normalized pouches at the start of the experi-
ment were 1.0 ± 0.03, but as injury onsets, the normalized width of 
the pouch reduces to 0.83 ± 0.03 at day 18 consistent with the in-
flammatory response and formation of ulcers. It is interesting to note 
that the ulcers completely heal by the end point analysis (day 28), yet 
the emergence of fibrotic tissue occurs and inhibits the pouch from 
regaining baseline elasticity (Figure 3A).
3.3 | Histopathology
Hematoxylin and eosin staining was conducted on paraffin-embed-
ded tissue sections to observe end point analysis of pouch morphol-
ogy in the hamsters that received 60 Gy (n = 22). Irradiated pouches 
were directly compared to baseline pouches (Figure 3B). At baseline, 
healthy intact epithelium was seen (black arrow) with normal mus-
cle and connective tissue. In the irradiated pouch (day 28), neutro-
philic and lymphocytic infiltration was observed in the submucosa 
(densely populated area with nuclei) and destruction of the epithe-
lium was still evident. Plump fibroblasts were seen throughout the 
sample as commonly seen in human patients that have been exposed 
F I G U R E  2   Method development of the RIOM using the LINAC. 
Experimental setup of the injury model (A), Dose-dependent pilot 
study to evaluate injury at 20 (n = 2), 40, and 60 Gy (n = 4 for 40 
and 60 Gy) (B), progression and evaluation of injury of a positive 
control in a large-scale animal study (n = 22) (C), and cheek pouch 
images of injury on days 0, 18, and 28 (D). Error bars depict 
Mean ± SEM
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to radiotherapy.13 The formation of dense fibrosis also was observed 
(blue arrow). These characteristics of fibrosis and epithelial slough-
ing align with the average score of 1.5 through the irradiated pouch 
population.
3.4 | ELISA analysis of pro-inflammatory and 
OS markers
To determine end point levels of pro-inflammatory and oxidative 
stress biomarker levels, TNF-α, IL-6, IL-10, protein carbonyl, and 
4-HNE were evaluated in the pouches that were exposed to 60 Gy 
(n = 22) using ELISAs and directly compared to nonirradiated pouches 
(n = 5) (Figure 3C). TNF-α, IL-10, and IL-6 did not have a significant 
difference at day 28 when compared to basal levels; however, the 
protein carbonyl levels were elevated from 2.01 ± 0.18 nmol/L/mg 
protein to 3.29 ±0.77 nmol/L/mg after radiation exposure compared 
to basal levels in unirradiated pouches. As protein carbonyl forma-
tion is a type of protein oxidation specific to reactive oxygen species, 
the elevated amount found in the exposed tissue supports the hy-
pothesis of oxidative damage. Furthermore, 4-HNE levels decreased 
from 0.338 ± 0.03 nmol/L/mg protein to 0.218 ± 0.07 nmol/L/mg 
protein in the exposure group compared to nonirradiated pouches. 
However, this change in marker level cannot be claimed as signifi-
cant, as the Dunnett’s test was used to analyze these populations of 
uneven sample size (n = 5 vs n = 22).
4  | DISCUSSION
Oral mucositis is a debilitating adverse effect of radiotherapy that 
is in need for an effective treatment. Animal models that closely 
mimic the human experience are also needed. In this study, doses 
were evaluated to achieve injury and resolution within a 28-day 
F I G U R E  3   End point analysis at day 28. Normalized quantitative values of extraction widths of irradiated cheek pouches at day 0 (start), 
day 18 (peak injury), and end (day 27) (A). Hematoxylin and eosin staining of a baseline cheek pouch compared to an irradiated cheek pouch 
at day 28. Black arrow represents intact/healthy epithelium, blue arrow represents inflammatory infiltrate, and white arrow represents 
disrupted epithelium. Representative images are shown at 10x magnification. (B). Oxidative and inflammatory biomarker analysis at day 28 of 
60 Gy exposure compared to basal levels (C). (n = 22, Mean ± SEM) *represents significance (P < .05) 
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experimental evaluation using a linear accelerator and provide end 
point analyses of pro-inflammatory markers, histological analysis, 
and elasticity of the hamster pouch. The linear accelerator radiation 
to the hamster cheek pouch resulted in injury that approximated mu-
cositis, with minimal variation and 100% survivability. At 40 Gy, lin-
ear accelerator radiation induced epithelial sloughing but no greater 
injury. In contrast, 60 Gy exposure induced ulcers that covered up 
to 50% of the exposed pouch, and apparent fibrosis after 28 days of 
evaluation. Peak injury, as determined using the OM rubric, occurred 
at day 18 and resolution of injury occurred by day 28.
An interesting finding was the modification to anesthetic dos-
ages when anesthetizing females vs males for the purpose of immo-
bilization during radiation exposure. A 10% increase in ketamine and 
xylazine to anesthetize female hamsters for the appropriate amount 
of time. While this has not been extensively studied in hamsters, 
there has been similar observation in mice, resulting in small thera-
peutic windows of anesthesia for female rodents.14
From our results, observational recognition of injury using photo 
documentation with scoring guidelines in the OM rubric in Table 1 
and elasticity measurements are both valuable ways to determine er-
ythema and sloughing as well as morphological changes during injury 
onset and progression throughout the study. These are helpful inter-
mediate evaluations to be able to conduct throughout the entire du-
ration of the study to understand impact of injury. End point analysis 
(day 28) was conducted to utilize pro-inflammatory marker analysis as 
well as H&E staining to understand radiation exposure effects to the 
tissue; however, the pro-inflammatory markers that were analyzed 
are hypothesized to be elevated specifically during the onset of in-
jury.15,16 When analyzed at a later time point (ie, day 28), the markers 
resolve below significantly different levels when compared to basal 
levels, which could be explained by resolution of gross injury. This 
hypothesis could be tested in future studies, specific to efficacy, by 
collecting tissue from euthanized animals during earlier time points 
and analyzing them for pro-inflammatory markers during onset of 
injury. Additionally, evidence also suggested that elevated oxidative 
stress, as determined by protein carbonyl formation, correlated with 
enhanced injury in this model. While HNE production was not ele-
vated (as would be expected in oxidative stress), HNE is a transient 
marker and not likely to persist as long as oxidized proteins may in the 
tissue bed. Further work would need to be conducted to determine if 
changes in extracellular matrix proteins (which may persist for longer 
periods of time) account for these elevated levels in protein carbonyl.
5  | CONCLUSIONS
Here, we show that use of the linear accelerator provides a relevance 
to human injury model during radiotherapy. Observational evalua-
tions, elasticity measurements, and biochemical findings of the 
cheek pouch are great characterization techniques to utilize for ef-
ficacy studies using the linear accelerator as source of acute injury. 
They can all be readily used for evaluating a multitude of different 
therapeutic methods of administration, such as topical, intravenous, 
and intraperitoneal, for the treatment of OM. Upon further valida-
tion, this model provides the opportunity to evaluate efficacy and 
effectiveness of developed and developing therapeutics to one day 
provide a cure for OM in cancer patients.
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